Nakajima M - Search Results

1

Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.

Nakajima M, Iwanari M, Yokoi T. Nakajima M, et al. Toxicol Lett. 2003 Sep 30;144(2):247-56. doi: 10.1016/s0378-4274(03)00216-9. Toxicol Lett. 2003. PMID: 12927368

2

Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.

Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T. Nakajima M, et al. Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):413-21. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 7920209

3

Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. J Pharmacol Exp Ther. 1996 May;277(2):1010-5. J Pharmacol Exp Ther. 1996. PMID: 8627511

4

Role of human cytochrome P4502A6 in C-oxidation of nicotine.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Drug Metab Dispos. 1996 Nov;24(11):1212-7. Drug Metab Dispos. 1996. PMID: 8937855

5

Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.

Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. Nakajima M, et al. Drug Metab Dispos. 1998 Mar;26(3):261-6. Drug Metab Dispos. 1998. PMID: 9492390

6

Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.

Kobayashi K, Nakajima M, Chiba K, Yamamoto T, Tani M, Ishizaki T, Kuroiwa Y. Kobayashi K, et al. Among authors: nakajima m. Br J Clin Pharmacol. 1998 Apr;45(4):361-8. doi: 10.1046/j.1365-2125.1998.t01-1-00692.x. Br J Clin Pharmacol. 1998. PMID: 9578183 Free PMC article.

7

Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.

Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T. Nakajima M, et al. Drug Metab Dispos. 1999 Jul;27(7):792-7. Drug Metab Dispos. 1999. PMID: 10383922

8

Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.

Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K. Kobayashi K, et al. Among authors: nakajima m. Drug Metab Dispos. 1999 Aug;27(8):860-5. Drug Metab Dispos. 1999. PMID: 10421611

9

Expression of calcium-binding protein regucalcin mRNA in the cloned rat hepatoma cells (H4-II-E) is stimulated through Ca2+ signaling factors: involvement of protein kinase C.

Nakajima M, Murata T, Yamaguchi M. Nakajima M, et al. Mol Cell Biochem. 1999 Aug;198(1-2):101-7. doi: 10.1023/a:1006996506238. Mol Cell Biochem. 1999. PMID: 10497883

10

Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.

Yamazaki H, Shibata A, Suzuki M, Nakajima M, Shimada N, Guengerich FP, Yokoi T. Yamazaki H, et al. Among authors: nakajima m. Drug Metab Dispos. 1999 Nov;27(11):1260-6. Drug Metab Dispos. 1999. PMID: 10534310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results